PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 22, 2024Cancer Research2 citations

Abstract 5137: BRAF mutations in primary central nervous system tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJuan Bautista BlaquierFDFulvio D’AngeloDTDalissa Tejera

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Blaquier et al. (2024) studied this question.

synapsesocial.com/papers/68e72bb1b6db6435876a5f7dhttps://doi.org/10.1158/1538-7445.am2024-5137
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PATH-77. Clinical and molecular predictors of survival and treatment response in AYA/adults with BRAF-V600 mutant high-grade glioma2025
  2. 2PATH-34. Assessment of BRAF alterations and recommended treatments in CNS tumors with BRAF alterations2025
  3. 3Abstract 4103: Dynamic co-mutation patterns and therapeutic implications in BRAF-altered malignancies: Evidence from AACR Project GENIE2026
  4. 4Abstract 2519: Characterization of BRAF fusions and their therapeutic and resistance implications in NSCLC2026
  5. 5H3K27M- and BRAF V600E -Altered gliomas and glioneuronal tumors—clinico-pathologic and radiologic perspective in a cohort treated with targeted therapy2025